SCHEMBL621111

SCHEMBL621111

O=C(c1cccc(O)c1O)C(O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.53
CES2 O00748 2/20 0.53
CES1 P23141 2/20 0.53
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 6/20 0.44
HPGD P15428 6/20 0.44
KDM4E B2RXH2 5/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA6 P23280 2/20 0.44
CA12 O43570 1/20 0.44
HMGB1 P09429 1/20 0.44
CA4 P22748 1/20 0.44
CA7 P43166 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CA9 Q16790 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HSD17B10 Q99714 4/20 0.43
TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL28820467 0.94 LMNA (0.47) LMNACES2CES1MAPK1ALDH1A1
Ether SCHEMBL28820451 0.89 LMNA (0.44) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL1940930 0.89 LMNA (0.53) LMNACES2CES1MAPK1ALDH1A1
Hydrochloric Acid SCHEMBL30424145 0.88 LMNA (0.52) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL252921 0.87 LMNA (0.59) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL10394795 0.83 MMP2 (0.58) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL30716847 0.83 ALB (0.58) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL27896734 0.83 LMNA (0.50) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL6558242 0.83 LMNA (0.50) LMNACES2CES1MAPK1ALDH1A1
SCHEMBL11056602 0.83 CA12 (0.52) LMNACES2CES1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118077891-A Composition containing lipase inhibitor and preparation method and application thereof 南京盛德创赢生物科技有限公司 2024-05-28 CN claimed
CN-115160848-B Preparation method of metal phthalocyanine modified titanium dioxide anti-yellowing agent 西安工业大学 2023-08-18 CN claimed
CN-110945066-A Halogen-free sulfonate and/or sulfinate esters as flame retardants, flame retardant synergists and free radical generators in plastics 弗劳恩霍弗应用研究促进协会 2020-03-31 CN claimed
EP-3423563-A1 IMPROVED MUCONIC ACID PRODUCTION FROM GENETICALLY ENGINEERED MICROORGANISMS Myriant Corporation (US) 2019-01-09 EP claimed
US-20180170937-A1 NEW SOLID FORMS OF SITAGLIPTIN ALPARIS, S.A. DE C.V. (MX) 2018-06-21 US claimed
WO-2013023999-A1 REGIOSELECTIVE CARBOXYLATION OF NONNATURAL SUBSTRATE COMPOUNDS USING DECARBOXYLASES ACIB GMBH (AT) 2013-02-21 WO claimed
JP-2007532569-A 2007-11-15 JP claimed
EP-1735260-A2 PURIFICATION OF CARBOXYLIC ACIDS BY COMPLEXATION WITH SELECTIVE SOLVENTS GTC Technology, Inc (US) 2006-12-27 EP claimed
WO-2006088470-A2 PURIFICATION OF CARBOXYLIC ACIDS BY COMPLEXATION WITH SELECTIVE SOLVENTS GTC TECHNOLOGY INC. (US) 2006-08-24 WO claimed
US-20050228195-A1 Purification of carboxylic acids by complexation with selective solvents GTC TECHNOLOGY, INC. 2005-10-13 US claimed
WO-2001085104-A1 USE OF MELANINS IN COMPOSITIONS FOR REMOVING MAKE-UP FROM AND/OR CLEANSING THE SKIN AND MUCOUS MEMBRANES GHISALBERTI CARLO (BR) 2001-11-15 WO claimed
EP-0453452-A4 VACCINE 1991-11-21 EP claimed
EP-0453452-A1 VACCINE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1991-10-30 EP claimed
WO-1990008184-A1 VACCINE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1990-07-26 WO claimed
EP-0322068-A1 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity ZAMBON GROUP S.p.A. (IT) 1989-06-28 EP claimed
EP-0169232-A1 Composition for technetium-99m labelling of proteinaceous material. INST ENERGITEKNIK (NO) 1986-01-29 EP claimed
WO-1985003231-A1 TECHNETIUM-99m COMPOSITION FOR LABELLING PROTEINACEOUS MATERIAL AND METHOD INSTITUTT FOR ENERGITEKNIKK (NO) 1985-08-01 WO claimed
JP-61051015-A None JP disclosed
US-4133729-A Production of 1,2-bis(hydroxy-phenyl)ethane-1,2-diols by electrolytic reduction MONSANTO COMPANY (US) 1979-01-09 US disclosed
US-4087336-A Electrolytic reductive coupling of hydroxybenzaldehydes MONSANTO COMPANY (US) 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180170937-A1 NEW SOLID FORMS OF SITAGLIPTIN DPP4, DPP3, DPP7 LMNA 4726/4885CES2 3546/4885CES1 1084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.